J&J Unit Can't Revive Dutch Infringement Claim Over Drug
A Dutch appeals court has rejected Janssen's claim that Samsung has infringed its patent over the Crohn's treatment Stelara by producing the drug on European Union soil with plans to export...To view the full article, register now.
Already a subscriber? Click here to view full article